Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

F2G

12 Disclosed Funding Rounds $213,319,363

0 Participating Investments


Pharmaceutical, Health Care, Genetics, Biotechnology, Medical

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

Manchester, Manchester, United Kingdom, Europe (GB)

Organizations in Manchester in Pharmaceutical,
Organizations in Manchester in Health Care,
Organizations in Manchester in Genetics,
Organizations in Manchester in Biotechnology,
Organizations in Manchester in Medical,
Organizations in Manchester in Pharmaceutical,
Organizations in Manchester in Health Care,
Organizations in Manchester in Genetics,
Organizations in Manchester in Biotechnology,
Organizations in Manchester in Medical,
Organizations in United Kingdom in Pharmaceutical,
Organizations in United Kingdom in Health Care,
Organizations in United Kingdom in Genetics,
Organizations in United Kingdom in Biotechnology,
Organizations in United Kingdom in Medical,
Organizations in Europe in Pharmaceutical,
Organizations in Europe in Health Care,
Organizations in Europe in Genetics,
Organizations in Europe in Biotechnology,
Organizations in Europe in Medical

Investors in Manchester in Pharmaceutical,
Investors in Manchester in Health Care,
Investors in Manchester in Genetics,
Investors in Manchester in Biotechnology,
Investors in Manchester in Medical,
Investors in Manchester in Pharmaceutical,
Investors in Manchester in Health Care,
Investors in Manchester in Genetics,
Investors in Manchester in Biotechnology,
Investors in Manchester in Medical,
Investors in United Kingdom in Pharmaceutical,
Investors in United Kingdom in Health Care,
Investors in United Kingdom in Genetics,
Investors in United Kingdom in Biotechnology,
Investors in United Kingdom in Medical,
Investors in Europe in Pharmaceutical,
Investors in Europe in Health Care,
Investors in Europe in Genetics,
Investors in Europe in Biotechnology,
Investors in Europe in Medical

Founded date 01, 1998

Founders David Denning

Operating Status Active

Last Funding Type Venture - Series Unknown

Company Type For Profit


LinkedIN Link

Wikipedia Link

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.

Date Round Raised Lead
August, 12, 2020 Venture - Series Unknown $60,800,000 Cowen Healthcare Investments
November, 22, 2018 Debt Financing $27,365,989 European Investment Bank
June, 20, 2016 Venture - Series Unknown $60,000,000 Sectoral Asset Management
September, 19, 2014 Grant $2,280,364 Innovate UK
September, 05, 2012 Venture - Series Unknown $30,000,000 Novartis Venture Fund
September, 05, 2012 Venture - Series Unknown Undisclosed -------
August, 18, 2008 Venture - Series Unknown $11,753,687 BankInvest Biomedical Venture
March, 22, 2006 Venture - Series Unknown $8,734,051 Astellas Venture Management
February, 10, 2006 Grant $200,871 -------
July, 01, 2004 Venture - Series Unknown $5,500,000 -------
August, 05, 2003 Venture - Series Unknown Undisclosed -------
September, 10, 2002 Series A $6,684,398 -------

F2G Investors (29)

Investor Lead? Round Participating Raise Date Partners
Brace Pharma No Venture - Series Unknown $60,800,000 August, 12, 2020 -------
Morningside Venture Partners No Venture - Series Unknown $60,800,000 August, 12, 2020 -------
Cowen Healthcare Investments Yes Venture - Series Unknown $60,800,000 August, 12, 2020 -------
Novo Ventures No Venture - Series Unknown $60,800,000 August, 12, 2020 -------
Advent Life Sciences No Venture - Series Unknown $60,800,000 August, 12, 2020 -------
European Investment Bank Yes Debt Financing $27,365,989 November, 22, 2018 -------
Sunstone Capital No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Sectoral Asset Management Yes Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Aisling Capital No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Brace Pharma No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Advent Life Sciences No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Novo Holdings No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Merifin Capital No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Novartis Venture Fund No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Sunstone Life Science Ventures No Venture - Series Unknown $60,000,000 June, 20, 2016 -------
Innovate UK Yes Grant $2,280,364 September, 19, 2014 -------
Merifin Capital No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
K Nominees No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Sunstone Capital No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Advent Venture Partners No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Novartis Venture Fund Yes Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Sunstone Life Science Ventures No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Astellas Venture Management No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Fraser No Venture - Series Unknown $30,000,000 September, 05, 2012 -------
Merifin Capital No Venture - Series Unknown $11,753,687 August, 18, 2008 -------
BankInvest Biomedical Venture Yes Venture - Series Unknown $11,753,687 August, 18, 2008 -------
K Nominees No Venture - Series Unknown $11,753,687 August, 18, 2008 -------
Astellas Venture Management No Venture - Series Unknown $11,753,687 August, 18, 2008 -------
Astellas Venture Management Yes Venture - Series Unknown $8,734,051 March, 22, 2006 -------